Pyrotinib Uses, Dosage, Side Effects and more
Pyrotinib is under investigation in clinical trial NCT03756064 (Neoadjuvant Study of Pyrotinib in Patients With HER2 Positive Breast Cancer).
Trade Name | Pyrotinib |
Generic | Pyrotinib |
Type | |
Formula | C32H31ClN6O3 |
Weight | Average: 583.09 Monoisotopic: 582.2146166 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |